|
|
|
|
C-907 / C-907-1ML updated item number format
Clonazepam
1.0 mg/mL in Methanol | Certified Reference Material
|
|
Clonazepam, marketed under trade names such as Klonopin and Rivotril, is a potent, long-acting benzodiazepine with anxiolytic, anticonvulsant, muscle relaxant and hypnotic properties. Clonazepam is prescribed for the treatment of epilepsy. This certified Snap-N-Spike® solution is suitable for use in GC/MS or LC/MS applications in forensic analysis, clinical toxicology, urine drug testing, or pain prescription monitoring.
|
|
|
|
|
| Concentration:
|
1.0 mg/mL
|
| Solvent:
|
Methanol
|
| Unit Size:
|
1 mL/ampoule
|
| CAS Number:
|
1622-61-3
|
| Chemical Formula:
|
C15H10ClN3O3
|
| Molecular Weight:
|
315.71
|
| Certificate of Analysis:
|
|
| US List Price:
|
|
|
|
|
| A-915 / A-915-1ML |
|
7-Aminoclonazepam, 100 μg/mL
|
|
$27.10
|
|
|
|
|
|
| A-916 / A-916-1ML |
|
7-Aminoclonazepam, 1.0 mg/mL
|
|
$112.00
|
|
|
|
|
|
| A-917 / A-917-1ML |
|
7-Aminoclonazepam-D4, 100 μg/mL
|
|
$46.90
|
|
|
|
|
|
| A-924 / A-924-1ML |
|
7-Aminoclonazepam-D4, 1.0 mg/mL
|
|
$462.00
|
|
|
|
|
|
| B-033 / B-033-1ML |
|
Benzodiazepine Multi-Component Mixture-8, 250 μg/mL of each component
|
|
$247.00
|
|
|
|
|
|
| C-905 / C-905-1ML |
|
Clonazepam-D4, 100 μg/mL
|
|
$46.90
|
|
|
|
|
|
| C-906 / C-906-1ML |
|
Clonazepam-D4, 1.0 mg/mL
|
|
$418.00
|
|
|
|
|
|
| F-043 / F-043-1ML |
|
Flubromazepam, 1.0 mg/mL
|
|
$144.00
|
|
|
|
|
|
| H-113 / H-113-1ML |
|
3-Hydroxyphenazepam, 1.0 mg/mL
|
|
$244.00
|
|
|
|
|
|
| P-093 / P-093-1ML |
|
Phenazepam-D4, 100 µg/mL
|
|
$241.00
|
|
|
|
|
Regulatory Control
▶ USDEA exempt chemical preparation - no USDEA registration or paperwork required
▶ Canada Test Kit Registration # 61-1110 - no Health Canada import authorization required
read more about ordering regulated substances
UN Number, Class, PG
1230, 3, II
Safety Data Sheet
HS Code
3822.90.0000
|
▶ High Throughput Screening and confirmation of 41 Pain Panel Drugs in Oral Fluid by an Integrated On-Line Extraction UHPLC-MS/MS System | Louis Maljers, Zicheng Yang, Bruker Daltonics Inc, 2016
|
|
▶ Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples | Robert M. Sears, Toxicology Technical Leader , Kenneth Lewis, CEO , and Kim Gamble, President, ITSP Solutions, INC., 2014
|
|
▶ Proof of Concept/Comparison of Automated SPE/HPLC/MS/MS Methods to Traditional Immunoassay with MS Confirmation in Death Investigation Cases | Robert M. Sears, Wendy C. Bell , Kenneth C. Lewis, Thurman L. Allsup and Kim Gamble, ITSP Solutions, INC., 2014
|
|
▶ Testing and Quantitation of Benzodiazepines in Urine and Serum by LC-TOF | Sharanya Reddy, Leslie Sullivan, George Perkins, PerkinElmer Inc., 2014
|
|
|
|
|